# DESCRIPTION

## FIELD OF THE INVENTION

- define genetic engineering field

## BACKGROUND

- motivate phosphatase control

## SUMMARY OF THE INVENTION

- relate genetic engineering to operons
- construct operons for biologically active agents
- describe fusion proteins with substrate recognition domains
- detail DNA sequences and binding sites
- introduce enzymes and reporter genes
- provide variations of substrate domains and enzymes
- contemplate systems for detecting inhibitors
- describe methods for evolving inhibitors and selective mutants
- detail methods for evolving photoswitchable enzymes
- contemplate microbial biosensors and their use
- provide fusion protein DNA constructs
- define fusion protein
- describe method of using fusion protein
- describe method for detecting small molecule modulator
- describe photoswitchable protein tyrosine phosphatase enzyme construct
- describe biosensor for enzyme activity
- describe genetically encoded system for detecting small molecules
- describe method for using genetically encoded system
- describe genetically encoded pathway for terpenoid biosynthesis
- describe method for identifying terpenoids that modulate enzyme activity
- describe inhibitor detection operon
- describe variations of genetically encoded system and pathway
- define genetically encoded detection operon system
- describe method of using inhibitor detection operon
- outline genetically encoded pathway for terpene biosynthesis
- describe method of using genetically encoded system for detecting small molecules
- outline engineered bacteria cell line
- describe phosphatase inhibitor molecule produced by bacteria

## DEFINITIONS

- define terms

## DETAILED DESCRIPTION OF INVENTION

- introduce genetic engineering of operons for biologically active agents
- describe applications of optogenetic and imaging technologies

### I. Protein Tyrosine Phosphatases (PTPs) and Protein Tyrosine Kinases (PTKs) in Relation to Disease.

- motivate PTPs and PTKs in disease
- describe photoswitchable constructs for controlling PTPs and PTKs
- discuss prior art on photocontrol of proteins
- describe protein tyrosine phosphatases (PTPs) and their role in disease
- motivate study of PTPs for therapeutic potential
- describe enzymatic phosphorylation of tyrosine residues

### II. Optogenetic Actuators.

- introduce optogenetic actuators
- limitations of existing technologies
- describe approach for controlling protein activity with light
- demonstrate approach on protein tyrosine phosphatase 1B (PTP1B)
- describe advantages over other exemplary technologies
- introduce "cage-free" approach to control protein tyrosine phosphatases and kinases with light
- develop photoswitchable variant of PTP1B
- describe experimental approach to develop photoswitchable PTP1B-LOV2 chimera
- discuss results of initial constructs and future studies
- outline objectives and expected outcomes
- Optimize chimera for in vitro cell studies
- Characterize PTP1B-substrate and PTP1B-protein interactions
- Investigate structural basis of photocontrol in PTP1BPS
- Develop approach for using confocal microscopy to study subcellular signaling events
- Examine localization of PTP1BPS in living cells
- Control PTP1BPS in living cells using confocal microscopy and FRET-based sensor
- Analyze relationships between PTP1BPS activation/inactivation and sensor phosphorylation
- Generalize approach to protein tyrosine phosphatases and kinases
- Develop exemplary photoswitch construct sequences and FRET sensors

### III. Genetically Encoded System for Constructing and Detecting Biologically Active Agents: Microbial Inhibitor Screening Systems.

- describe operon development for microbial inhibitor screening
- outline operon functions for detecting biologically active molecules
- introduce protein evolving systems for biologically active metabolites
- discuss evolving molecules for drug leads
- hypothesize structurally varied terpenoids for PTP1B inhibition
- examine molecular basis of affinity and activity in enzyme-terpenoid interactions
- evolve high-affinity terpenoid inhibitors of PTP1B
- introduce synthetic biology approach
- describe limitations of current methods
- propose new strategy for constructing and detecting biologically active agents
- highlight advantages of new approach over existing methods
- describe high-throughput metabolic engineering
- identify new inhibitors using abietadiene as a starting point
- engineer E. coli to produce abietadiene
- assess ability of minor structural perturbations to yield improved inhibitors
- functionalize abietadiene using cytochrome P450bm3 mutants
- outline research plan for developing structurally varied terpenoids with different affinities for PTP1B

### IV. Evolving High-Affinity Terpenoid Inhibitors of PTP1B.

- develop high-throughput screens for PTP1B inhibitors
- design biological selection method for inhibitor potency
- create FRET sensors for PTP1B activity and conformational changes
- apply mutagenesis to evolve terpenoid inhibitors
- develop biophysical framework for identifying enzymes capable of synthesizing inhibitors

### VI. Evolving Optogenetic Actuators: Photoswitchable Constructs.

- motivate red and infrared light control
- describe operon for evolving photoswitchable constructs
- outline directed evolution approach
- describe extension to STEP and PTK6
- outline biophysical characterization of enzyme-phytochrome chimeras
- discuss advantages of using operons

## ABBREVIATIONS

- define abbreviations

## Examples

- illustrate embodiments

